Diakonos Oncology is pioneering cancer treatment with DOC1021, an FDA Fast Track-designated "double-loaded" dendritic cell therapy for glioblastoma (GBM) and pancreatic cancer (PDAC). This personalized, autologous therapy has shown exceptional safety and efficacy, achieving an 88% 12-month survival ...
Use this information to figure out if this company is an ideal customer for you.
(832) 746-xxxx
1110 Nasa Parkway
Houston, 77058
Diakonos Oncology's CEO is Mike Wicks
Diakonos Oncology's HQ is located at 1110 Nasa Parkway, Houston
Diakonos Oncology's phone number is (832) 746-xxxx
Diakonos Oncology's official website is diakonosoncology.com
Diakonos Oncology's revenue is $0 - $100k
Diakonos Oncology has 51 - 200 employees
Diakonos Oncology is in the industry of: Pharmaceuticals